OS Therapies Inc OSTX Stock Analysis
- NYSE American
- Stock
- Market closed · opens Monday 9:30 AM ET
$1.32 down $0.09, 6.38% at close Oct 16
Last close · Previous close $1.41
- Market cap
- $58.79MAt the Oct 16 close
- P/E ratio
- n/mLoss over last 12 months
- Diluted EPS
- −$1.09Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$1.32down $0.09, 6.38%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$1.41Oct 15
- Volume529.17KOct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume753.61KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $1.15 to $2.25; now $1.32
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
OSTX trailed the S&P 500 in all 4 periods.
| Period | OSTX and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | OSTX: down 24.6% S&P 500: up 1.5% | OSTX trailed the S&P 500 by 26.1 percentage points Trailed |
| 3M | OSTX: down 12.0% S&P 500: up 1.9% | OSTX trailed the S&P 500 by 13.9 percentage points Trailed |
| YTD | OSTX: down 5.7% S&P 500: up 12.8% | OSTX trailed the S&P 500 by 18.5 percentage points Trailed |
| 1Y | OSTX: down 28.6% S&P 500: up 16.8% | OSTX trailed the S&P 500 by 45.4 percentage points Trailed |
$10,000 invested in OSTX a year ago (Oct 16, 2025) would be worth about $7,135 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $11,678.
OSTX trailed the S&P 500 in all 4 periods.
| Period | OSTX and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | OSTX: down 24.6% S&P 500: up 1.2% | OSTX trailed the S&P 500 by 25.8 percentage points Trailed |
| 3M | OSTX: down 12.0% S&P 500: up 1.7% | OSTX trailed the S&P 500 by 13.7 percentage points Trailed |
| YTD | OSTX: down 5.7% S&P 500: up 11.9% | OSTX trailed the S&P 500 by 17.6 percentage points Trailed |
| 1Y | OSTX: down 28.6% S&P 500: up 15.5% | OSTX trailed the S&P 500 by 44.1 percentage points Trailed |
$10,000 invested in OSTX a year ago (Oct 16, 2025) would be worth about $7,135 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $11,553.
All-time high
$5.16
Closing high on . Now 74.4% below that record.
Split-adjusted daily closes since Aug 1, 2024.
Stock splits
OSTX hasn’t split since its price history begins in 2024.
Valuation
The Oct 16 close compared with the last 12 months of reported results (the four quarters to Jun 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
n/mDiluted EPS of −$1.09 over the last 12 months
A P/E ratio isn’t meaningful while earnings over the last 12 months are negative. How to read P/E
Other valuation measures
- −31.52%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $58.59MAt the Oct 16 close
What it would cost to buy the whole business: the market cap at the Oct 16 close, plus debt, minus cash and short-term investments from the Jun 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own OSTX DCF in Excel. Value OS Therapies with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $0.00
- Net income
- −$39.37M
- Diluted EPS
- −$1.09
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $0.00 | −$2.88M | −$0.18 |
| Q4 FY24 (Dec 31, 2024) | $0.00 | −$2.99M | −$0.64 |
| Q1 FY25 (Mar 31, 2025) | $0.00 | −$3.88M | −$0.18 |
| Q2 FY25 (Jun 30, 2025) | $0.00 | −$4.54M | −$0.19 |
| Q3 FY25 (Sep 30, 2025) | $0.00 | −$6.88M | −$0.21 |
| Q4 FY25 (Dec 31, 2025) | $0.00 | −$13.46M | −$0.41 |
| Q1 FY26 (Mar 31, 2026) | $0.00 | −$10.40M | −$0.27 |
| Q2 FY26 (Jun 30, 2026) | $0.00 | −$8.63M | −$0.20 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $0.00 | −$7.42M | −$1.50 |
| FY22 (Dec 31, 2022) | $0.00 | −$6.25M | −$1.28 |
| FY23 (Dec 31, 2023) | $0.00 | −$7.79M | −$1.46 |
| FY24 (Dec 31, 2024) | $0.00 | −$8.88M | −$1.28 |
| FY25 (Dec 31, 2025) | $0.00 | −$28.75M | −$0.98 |
Margins
- Gross —
- Operating —
- Net —
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$18.53MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$18.53MLast 12 months
- Capital spending$0.00Last 12 months
Shareholder returns
- $13.57MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
Balance sheet
- $205.04KAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$0.00As of Jun 30, 2026
- Net cash$205.04KAs of Jun 30, 2026
- 0.18As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio
Financial strength
- −477.4%Last 12 months
Over the last 12 months, OS Therapies’s net loss was 477.4% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
About OS Therapies Inc
OS Therapies Inc
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Maryland, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- NYSE American
- Asset type
- Common stock
- Price history since
OSTX news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
OSTX stock FAQ
What is OSTX stock’s price today?
OS Therapies (OSTX) traded at $1.32 at the close on , down $0.09 (6.38%) from the previous close of $1.41. Over the past 52 weeks it has traded between $1.15 and $2.25.
What is OS Therapies’s market cap?
OS Therapies’s market capitalization is about $58.8 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $1.32 (how market cap works). OS Therapies reported 44.54M shares outstanding at the end of its latest quarter ().
What is OSTX’s P/E ratio?
OSTX’s P/E ratio isn’t meaningful right now because its earnings over the four quarters to are negative (diluted EPS of −$1.09).
What are OSTX’s earnings per share?
OSTX’s diluted earnings per share were −$1.09 over the four quarters to , compared with −$1.19 in the twelve months before. The latest quarter (Q2 FY26) brought −$0.20 per share, against −$0.19 a year earlier (how EPS works).
Does OSTX pay a dividend?
OS Therapies hasn’t paid a dividend in the last twelve months.
What is OSTX’s 52-week high and low?
Over the past 52 weeks OSTX has traded as low as $1.15 and as high as $2.25. At $1.32 at the close on , it is 41.3% below that high and 14.8% above the low.
What is OSTX’s all-time high?
OSTX’s highest closing price was $5.16 on , adjusted for stock splits. At $1.32 at the close on , it is 74.4% below that record.
Has OSTX stock ever split?
No. OSTX hasn’t split since its price history begins in 2024.
How has OSTX stock performed?
Including dividends and measured to the close on , OSTX has returned −5.7% so far this year and −28.6% over the past year. Over the same periods the S&P 500, measured by SPY, returned +12.8% and +16.8%. Past performance doesn’t predict future returns.
What sector and industry is OS Therapies in?
OS Therapies is in the Healthcare sector and the Biotechnology industry, and is headquartered in Maryland, USA.
What exchange does OSTX trade on?
OS Therapies trades on the NYSE American under the ticker symbol OSTX. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.